EVENTS · QGEN
PEERS
EARNINGS
Moving with Diagnostics & Research
| Series | 1W | 1M |
|---|---|---|
| QGEN | +1.0% | +11.3% |
| Peers | −1.5% | +9.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 31 | 62 |
Agreed to be acquired. Similar cash deals closed 91% of the time (n=628), typically 93 days after announcement, around Jan 22, 2027 for this one.
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q3 FY2026 | 0.63 | 0.65 | +2.43% | — |
| Q2 FY2026 | 0.61 | 0.62 | +1.59% | — |
| Q1 FY2026 | 0.55 | 0.54 | −2.09% | −1.44% |
| Q4 FY2025 | 0.64 | 0.62 | −3.03% | −1.27% |
| Q3 FY2025 | — | — | — | −3.57% |
| Series | 1W | 1M |
|---|---|---|
| QGEN | +1.0% | +11.3% |
| Peers | −1.5% | +9.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 31 | 62 |
